High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma
Cancer Gene Therapy - United Kingdom
doi 10.1038/s41417-018-0070-x
Full Text
Open PDFAbstract
Available in full text
Date
January 9, 2019
Authors
Publisher
Springer Science and Business Media LLC